日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A pilot trial of ocrelizumab for modulation of meningeal enhancement in multiple sclerosis

奥克瑞珠单抗用于调节多发性硬化症脑膜增强的试点试验

Dahal, Shishir; Allette, Yohance M; Naunton, Kerry; Harrison, Daniel M

Meningeal contrast enhancement in multiple sclerosis: Assessment of field strength, acquisition delay, and clinical relevance

多发性硬化症脑膜对比增强:磁场强度、采集延迟和临床相关性的评估

Harrison, Daniel M; Allette, Yohance M; Zeng, Yuxin; Cohen, Amanda; Dahal, Shishir; Choi, Seongjin; Zhuo, Jiachen; Hua, Jun

Meningeal contrast enhancement in multiple sclerosis: assessment of field strength, acquisition delay, and clinical relevance

多发性硬化症脑膜对比增强:磁场强度、采集延迟和临床相关性的评估

Harrison, Daniel M; Allette, Yohance M; Zeng, Yuxin; Cohen, Amanda; Dahal, Shishir; Choi, Seongjin; Zhuo, Jiachen; Hua, Jun

Decoy peptide targeted to Toll-IL-1R domain inhibits LPS and TLR4-active metabolite morphine-3 glucuronide sensitization of sensory neurons

靶向Toll-IL-1R结构域的诱饵肽抑制LPS和TLR4活性代谢物吗啡-3葡糖醛酸苷对感觉神经元的致敏作用

Allette, Yohance M; Kim, Youngsook; Randolph, Aaron L; Smith, Jared A; Ripsch, Matthew S; White, Fletcher A

Acrolein involvement in sensory and behavioral hypersensitivity following spinal cord injury in the rat.

丙烯醛参与大鼠脊髓损伤后的感觉和行为过敏

Due Michael R, Park Jonghyuck, Zheng Lingxing, Walls Michael, Allette Yohance M, White Fletcher A, Shi Riyi

Suppression of pain-related behavior in two distinct rodent models of peripheral neuropathy by a homopolyarginine-conjugated CRMP2 peptide

同聚精氨酸缀合的CRMP2肽在两种不同的啮齿动物周围神经病变模型中均能抑制疼痛相关行为。

Ju, Weina; Li, Qi; Allette, Yohance M; Ripsch, Matthew S; White, Fletcher A; Khanna, Rajesh